Clinicodemographic Profile of Adult Patients With Chronic Urticaria in an Allergy Specialty Clinic
A Five-Year Review (2019 to 2023)
DOI:
https://doi.org/10.70552/pjaai.24.2.10983Keywords:
urticaria, prevalence, clinicodemographic featuresAbstract
Background: There is variability among the prevalence and characteristics of chronic urticaria.
Objectives: This study aimed to determine clinicodemographic characteristics of adult patients diagnosed with chronic urticaria in an allergy clinic in Metro Manila, Philippines, from 2019 to 2023.
Methodology: A cross-sectional review of medical records from patients aged 19 and above at an allergy clinic in Metro Manila was conducted from 2019 to 2023. Clinicodemographic features, along with their frequencies and percentages, were obtained.
Results: Seventy-five patients with chronic urticaria were investigated. The majority were women (72%) aged 30 to 39 (30.7%) from the National Capital Region (85.3%). Most were married (36%), college graduates (30.7%), and employed (54.7%), with 62.7% seeking their initial consultation 2 to 12 months after the onset of the disease. Fifty-seven percent of patients had a personal history of atopy and 54.7% had a family history of atopy. Thirty-seven percent of patients had comorbidities, with hypertension as the most frequent (18.7%). Thirty-three percent of patients were suspected with chronic inducible urticaria with dermographism as the most common suspected trigger (21.3%). Fifty-eight percent of patients had urticaria before COVID-19 vaccination, while 42% had a previous history of COVID-19 vaccine before the onset of symptoms. However, no further tests were done to confirm its association with the disease. Fifteen patients underwent skin prick tests, and all demonstrated positive skin test reactivity to some form of aeroallergen or food allergens. All patients were given second-generation H1-antihistamine at varying doses. The majority of patients (65.3%) reported an improvement in symptoms. Only 26.7% of patients used the 7-day Urticaria Activity Score, while 29.3% used the Urticaria Control Test to monitor their symptoms.
Conclusion: The prevalence of chronic urticaria (13%) was higher than the global estimate of 1%. Most chronic urticaria patients were female, aged 30 to 39, married, college graduates, and employed who showed symptoms within 2 to 12 months after the onset of the disease. Approximately 50% of them had a personal and family history of atopy. Most patients do not have comorbidities and suspected inducible triggers. All patients who underwent skin prick tests showed reactivity to some allergens (aeroallergens, food allergens). All patients were given second-generation H1-antihistamines at varying doses. Many patients experienced symptom improvement with the prescribed medications despite poor compliance with the recommended monitoring tools. According to clinical history, the onset of chronic urticaria was not attributed to COVID-19 vaccination in most cases.
References
Fricke J, Ávila G, Keller T, et al T. Prevalence of chronic urticaria in children and adults across the globe: Systematic review with meta-analysis. Allergy. 2020;75(2):423-32. https://pubmed.ncbi.nlm.nih.gov/31494963 https://doi.org/10.1111/all.14037 DOI: https://doi.org/10.1111/all.14037
Gold-Olufadi S, Ayanlowo O, Akinkugbe AO, Otrofanowei E. Clinical and aetiologic profile of patients with chronic urticaria at the outpatient clinic of a tertiary hospital in Lagos, Nigeria: a cross-sectional observational study. Pan Afr Med J. 2021;40:141. https://pubmed.ncbi.nlm.nih.gov/34925676 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654876 https://doi.org/10.11604/pamj.2021.40.141.27655
Mostmans Y, Richert B, De Maertelaer V, et al. Chronic spontaneous urticaria in belgium: deciphering the clinical profile and treatment of patients visiting an urban city Immunology Department. Dermatology. 2023;239(6):926-36. https://pubmed.ncbi.nlm.nih.gov/37634502 https://doi.org/10.1159/000533394 DOI: https://doi.org/10.1159/000533394
Paudel S , Parajuli N , Sharma R , Parajuli S . Chronic spontaneous urticaria: clinical profile, autologous serum skin test positivity and associated impairment in quality of life in Nepalese patients. Kathmandu Univ Med J (KUMJ). 2022;20(80):448-51. https://pubmed.ncbi.nlm.nih.gov/37795722 DOI: https://doi.org/10.3126/kumj.v20i4.54083
Gonçalo M, Gimenéz-Arnau A, Al-Ahmad M, et al. The global burden of chronic urticaria for the patient and society. Br J Dermatol. 2021;184(2):226-36. https://pubmed.ncbi.nlm.nih.gov/32956489 https://doi.org/10.1111/bjd.19561 DOI: https://doi.org/10.1111/bjd.19561
Kulthanan K, Chusakul S, Recto MT, et al. Economic burden of the inadequate management of allergic rhinitis and urticaria in Asian countries based on the GA²LEN model. Allergy Asthma Immunol Res. 2018;10(4):370-8. https://pubmed.ncbi.nlm.nih.gov/29949833 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021592 https://doi.org/10.4168/aair.2018.10.4.370 DOI: https://doi.org/10.4168/aair.2018.10.4.370
Sánchez J, Amaya E, Acevedo A, Celis A, Caraballo D, Cardona R. Prevalence of inducible urticaria in patients with chronic spontaneous urticaria: associated risk factors. J Allergy Clin Immunol Pract. 2017;5(2):464-70. https://pubmed.ncbi.nlm.nih.gov/27838325 https://doi.org/10.1016/j.jaip.2016.09.029 DOI: https://doi.org/10.1016/j.jaip.2016.09.029
Muntean IA, Pintea I, Bocsan IC, Dobrican CT, Deleanu D. COVID-19 disease leading to chronic spontaneous urticaria exacerbation: a Romanian retrospective Study. Healthcare (Basel). 2021;9(9):1144. https://pubmed.ncbi.nlm.nih.gov/34574918 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470475 https://doi.org/10.3390/healthcare9091144 DOI: https://doi.org/10.3390/healthcare9091144
Chow SK. Management of chronic urticaria in Asia: 2010 AADV consensus guidelines. Asia Pac Allergy. 2012;2(2):149-60. https://pubmed.ncbi.nlm.nih.gov/22701866 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3345329 https://doi.org/10.5415/apallergy.2012.2.2.149 DOI: https://doi.org/10.5415/apallergy.2012.2.2.149
Zuberbier T, Bernstein JA, Maurer M. Chronic spontaneous urticaria guidelines: What is new? J Allergy Clin Immunol. 2022;150(6):1249-55. https://pubmed.ncbi.nlm.nih.gov/36481045 https://doi.org/10.1016/j.jaci.2022.10.004. Erratum in: J Allergy Clin Immunol. 2023;151(2):580. https://pubmed.ncbi.nlm.nih.gov/36740329 https://doi.org/10.1016/j.jaci.2022.12.804 DOI: https://doi.org/10.1016/j.jaci.2022.10.004
Burks AW, O'Hehir RE, Broide DH, et al, eds. Middleton's allergy: principles and practice, 9th ed. Edinburgh: Elsevier Health Sciences; 2020.
Jo YH, Yoo HW, Kim SH, Kim YM, Kim HY. Clinical characteristics and treatment response of chronic spontaneous urticaria according to age: a single-center Korean study. Asian Pac J Allergy Immunol. 2022;40(4):374-8. https://pubmed.ncbi.nlm.nih.gov/31837210 https://doi.org/10.12932/AP-050719-0594 DOI: https://doi.org/10.12932/AP-050719-0594
Lee HC, Hong JB, Chu CY. Chronic idiopathic urticaria in Taiwan: a clinical study of demographics, aggravating factors, laboratory findings, serum autoreactivity and treatment response. J Formos Med Assoc. 2011;110(3):175-82. https://pubmed.ncbi.nlm.nih.gov/21497281 https://doi.org/10.1016/S0929-6646(11)60028-4 DOI: https://doi.org/10.1016/S0929-6646(11)60028-4
Alen Coutinho I, Regateiro FS, Fernandes RA, et al. Refractory chronic urticaria in adults: clinical characterization and predictors of severity. Allergy Asthma Clin Immunol. 2020;16(1):97. https://pubmed.ncbi.nlm.nih.gov/33292453 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661155 https://doi.org/10.1186/s13223-020-00496-0 DOI: https://doi.org/10.1186/s13223-020-00496-0
Abuelgasim E, Dona ACM, Sondh RS, Harky A. Management of urticaria in COVID-19 patients: a systematic review. Dermatol Ther. 2021;34(1):e14328. https://pubmed.ncbi.nlm.nih.gov/32986289 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536947 https://doi.org/10.1111/dth.14328 DOI: https://doi.org/10.1111/dth.14328
Gaig P, Olona M, Muñoz Lejarazu D, et al. Epidemiology of urticaria in Spain. J Investig Allergol Clin Immunol. 2004;14(3):214-20. https://pubmed.ncbi.nlm.nih.gov/15552715.
Justiz Vaillant AA, Modi P, Jan A. Atopy. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. https://pubmed.ncbi.nlm.nih.gov/31194344
Shalom G, Magen E, Babaev M, et al. Chronic urticaria and the metabolic syndrome: a cross-sectional community-based study of 11 261 patients. J Eur Acad Dermatol Venereol. 2018;32(2):276-81. https://pubmed.ncbi.nlm.nih.gov/28846167 https://doi.org/10.1111/jdv.14548 DOI: https://doi.org/10.1111/jdv.14548
Duperrex O, Tommasini F, Muller YD. Incidence of chronic spontaneous urticaria following receipt of the COVID-19 vaccine booster in Switzerland. JAMA Netw Open. 2023;6(2):e2254298. https://doi.org/10.1001/jamanetworkopen.2022.54298. Erratum in: JAMA Netw Open. 2023;6(4):e239463. DOI: https://doi.org/10.1001/jamanetworkopen.2022.54298
de Montjoye L, Herman A, Baeck M. Chronic spontaneous urticaria following COVID-19 vaccination. JAAD Case Rep. 2022;25:35-8. https://pubmed.ncbi.nlm.nih.gov/35615160 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123822 https://doi.org/10.1016/j.jdcr.2022.05.011 DOI: https://doi.org/10.1016/j.jdcr.2022.05.011
Tuchinda P, Kulthanan K, Chularojanamontri L, Pongkittilar B, Pochanapan O, Rujitharanawong C. Disease activity of patients with chronic urticaria receiving COVID-19 vaccines. Asian Pac J Allergy Immunol. 2024;42(2):123-31. https://pubmed.ncbi.nlm.nih.gov/36278777 https://doi.org/10.12932/AP-160322-1345 DOI: https://doi.org/10.12932/AP-160322-1345
Cherrez-Ojeda I, Bousquet J, Giménez-Arnau A, et al. Patient-reported outcome measures in atopic dermatitis and chronic urticaria are underused in clinical practice. J Allergy Clin Immunol Pract. 2024;12(6):1575-83.e1. https://pubmed.ncbi.nlm.nih.gov/38604531 https://doi.org/10.1016/j.jaip.2024.03.050. Erratum in: J Allergy Clin Immunol Pract. 2024;12(7):1950. https://doi.org/10.1016/j.jaip.2024.06.013 DOI: https://doi.org/10.1016/j.jaip.2024.06.013
Sánchez-Borges M, Asero R; WAO Scientific and Clinical Issues Council. Diagnosis and treatment of urticaria and angioedema: a worldwide perspective. World Allergy Organ J. 2012;5(11):125-47. https://pubmed.ncbi.nlm.nih.gov/23282382 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651155 https://doi.org/10.1097/WOX.0b013e3182758d6c DOI: https://doi.org/10.1097/WOX.0b013e3182758d6c
Kim JH, Jung SM, Choi IH, Kim MH, Kang MS. Trends of using UAS7 in Chronic Urticaria Literature and Adherence of UAS7 in a Single Korean Medical Hospital. The J Korean Med Ophthalmol Otolaryngol Dermatol. 2021;34(1):29-43. https://doi.org/10.6115/jkood.2021.34.1.029. DOI: https://doi.org/10.7580/kjlm.2021.45.1.34
Prosty C, Gabrielli S, Mule P, et al. Validation of the Urticaria Control Test (UCT) in children with chronic urticaria. J Allergy Clin Immunol Pract. 2022;10(12):3293-8.e2. https://pubmed.ncbi.nlm.nih.gov/35973527 https://doi.org/10.1016/j.jaip.2022.07.037 DOI: https://doi.org/10.1016/j.jaip.2022.07.037
Kulthanan K, Chularojanamontri L, Tuchinda P, Rujitharanawong C, Maurer M, Weller K. Validity, reliability and interpretability of the Thai version of the urticaria control test (UCT). Health Qual Life Outcomes. 2016;14:61. https://pubmed.ncbi.nlm.nih.gov/27075142 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831163 https://doi.org/10.1186/s12955-016-0466-y DOI: https://doi.org/10.1186/s12955-016-0466-y
Kulthanan K, Jiamton S, Rutnin NO, Insawang M, Pinkaew S. Prevalence and relevance of the positivity of skin prick testing in patients with chronic urticaria. J Dermatol. 2008;35(6):330-5. https://pubmed.ncbi.nlm.nih.gov/18578709 https://doi.org/10.1111/j.1346-8138.2008.00477.x DOI: https://doi.org/10.1111/j.1346-8138.2008.00477.x
Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018;73(7):1393-1414. https://pubmed.ncbi.nlm.nih.gov/29336054 https://doi.org/10.1111/all.13397 DOI: https://doi.org/10.1111/all.13397
Hollis K, Proctor C, McBride D, et al. Comparison of Urticaria Activity Score Over 7 Days (UAS7) values obtained from once-daily and twice-daily versions: results from the ASSURE-CSU Study. Am J Clin Dermatol. 2018;19(2):267-74. https://pubmed.ncbi.nlm.nih.gov/29368043 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978890 https://doi.org/10.1007/s40257-017-0331-8 DOI: https://doi.org/10.1007/s40257-017-0331-8
Abernethy AP, Herndon JE 2nd, Wheeler JL, et al. Feasibility and acceptability to patients of a longitudinal system for evaluating cancer-related symptoms and quality of life: pilot study of an e/Tablet data-collection system in academic oncology. J Pain Symptom Manage. 2009;37(6):1027-38. https://pubmed.ncbi.nlm.nih.gov/19394793 https://doi.org/10.1016/j.jpainsymman.2008.07.011 DOI: https://doi.org/10.1016/j.jpainsymman.2008.07.011
Lapi F, Cassano N, Pegoraro V, et al. Epidemiology of chronic spontaneous urticaria: results from a nationwide, population-based study in Italy. Br J Dermatol. 2016;174(5):996-1004. https://pubmed.ncbi.nlm.nih.gov/26872037 https://doi.org/10.1111/bjd.14470 DOI: https://doi.org/10.1111/bjd.14470
Navarro-Locsin CG, Lim-Jurado M. Aeroallergen sensitization and associated comorbid diseases of an adult Filipino population with allergic rhinitis. Asia Pac Allergy. 2018;8(3):e25. https://pubmed.ncbi.nlm.nih.gov/30079303 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073179 https://doi.org/10.5415/apallergy.2018.8.e25 DOI: https://doi.org/10.5415/apallergy.2018.8.e25
Capuno JJ, Kraft AD, Poco LC, Quimbo SA, Tan CAR Jr. Health conditions, payments, proximity, and opportunity costs: examining delays in seeking inpatient and outpatient care in the Philippines. Soc Sci Med. 2019;238:112479. https://pubmed.ncbi.nlm.nih.gov/31421350 https://doi.org/10.1016/j.socscimed.2019.112479 DOI: https://doi.org/10.1016/j.socscimed.2019.112479
Neale AV, Tilley BC, Vernon SW. Marital status, delay in seeking treatment and survival from breast cancer. Soc Sci Med. 1986;23(3):305-12. https://pubmed.ncbi.nlm.nih.gov/3764489 https://doi.org/10.1016/0277-9536(86)90352-7 DOI: https://doi.org/10.1016/0277-9536(86)90352-7
Jankowska-Konsur A, Reich A, Szepietowski J; Polish Chronic Urticaria Working Group. Clinical characteristics and epidemiology of chronic urticaria: a nationwide, multicentre study on 1091 patients. Postepy Dermatol Alergol. 2019;36(2):184-91. https://pubmed.ncbi.nlm.nih.gov/31320852 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627267 https://doi.org/10.5114/ada.2019.84594 DOI: https://doi.org/10.5114/ada.2019.84594
Pereira ARF, Motta AA, Kalil J, Agondi RC. Chronic inducible urticaria: confirmation through challenge tests and response to treatment. Einstein (Sao Paulo). 2020;18:eAO5175. https://pubmed.ncbi.nlm.nih.gov/32667419 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334002 https://doi.org/10.31744/einstein_journal/2020ao5175 DOI: https://doi.org/10.31744/einstein_journal/2020AO5175
Ornek Ozdemir S, Kuteyla Can P, Degirmentepe EN, Cure K, Singer R, Kocaturk E. A comparative analysis of chronic inducible urticaria in 423 patients: clinical and laboratory features and comorbid conditions. J Eur Acad Dermatol Venereol. 2024;38(3):513-20. https://pubmed.ncbi.nlm.nih.gov/37991240 https://doi.org/10.1111/jdv.19637 DOI: https://doi.org/10.1111/jdv.19637
Papapostolou N, Xepapadaki P, Katoulis A, Makris M. Comorbidities of chronic urticaria: A glimpse into a complex relationship. Front Allergy. 2022;3:1008145. https://pubmed.ncbi.nlm.nih.gov/36465885 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712803 https://doi.org/10.3389/falgy.2022.1008145 DOI: https://doi.org/10.3389/falgy.2022.1008145
Nebiolo F, Bergia R, Bommarito L, et al. Effect of arterial hypertension on chronic urticaria duration. Ann Allergy Asthma Immunol. 2009;103(5):407-10. https://pubmed.ncbi.nlm.nih.gov/19927539 https://doi.org/10.1016/S1081-1206(10)60360-2 DOI: https://doi.org/10.1016/S1081-1206(10)60360-2
Ghazanfar MN, Kibsgaard L, Thomsen SF, Vestergaard C. Risk of comorbidities in patients diagnosed with chronic urticaria: A nationwide registry-study. World Allergy Organ J. 2020;13(1):100097. https://pubmed.ncbi.nlm.nih.gov/32021661 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994395 https://doi.org/10.1016/j.waojou.2019.100097 DOI: https://doi.org/10.1016/j.waojou.2019.100097
Chen YJ, Wu CY, Shen JL, Chen TT, Chang YT. Cancer risk in patients with chronic urticaria: a population-based cohort study. Arch Dermatol. 2012;148(1):103-8. https://pubmed.ncbi.nlm.nih.gov/22250240 https://doi.org/10.1001/archdermatol.2011.682 DOI: https://doi.org/10.1001/archdermatol.2011.682
Royal-Preyra B, Boucher M, Marsan I. Urticaria heralding breast cancer: case report and literature review. Adv Radiat Oncol. 2023;9(4):101433. https://pubmed.ncbi.nlm.nih.gov/38435967 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10906169 https://doi.org/10.1016/j.adro.2023.101433 DOI: https://doi.org/10.1016/j.adro.2023.101433
Seo JH, Kwon JW. Epidemiology of urticaria including physical urticaria and angioedema in Korea. Korean J Intern Med. 2019;34(2):418-25. https://pubmed.ncbi.nlm.nih.gov/29742892 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406086 https://doi.org/10.3904/kjim.2017.203 DOI: https://doi.org/10.3904/kjim.2017.203
Dolipas-Tolentino TS, Sumpaico MW, Castor MA, Recto MS, De Leon JC. Clinical profile of pediatric patients with chronic urticaria: a five year review. Philipp J Allergy Asthma Immunol. 2009;14(2): 1-13.
Wong MM, Keith PK. Presence of positive skin prick tests to inhalant allergens and markers of T2 inflammation in subjects with chronic spontaneous urticaria (CSU): a systematic literature review. Allergy Asthma Clin Immunol. 2020;16:72. https://pubmed.ncbi.nlm.nih.gov/32944029 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491258 https://doi.org/10.1186/s13223-020-00461-x DOI: https://doi.org/10.1186/s13223-020-00461-x
Kocatürk E, Muñoz M, Elieh-Ali-Komi D, et al. How infection and vaccination are linked to acute and chronic urticaria: a special focus on COVID-19. Viruses. 2023;15(7):1585. https://pubmed.ncbi.nlm.nih.gov/37515272 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386070 https://doi.org/10.3390/v15071585 DOI: https://doi.org/10.3390/v15071585
Zhao Z, Cai T, Chen H, et al. Expert consensus on the use of omalizumab in chronic urticaria in China. World Allergy Organ J. 2021;14(11):100610. https://pubmed.ncbi.nlm.nih.gov/34934470 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654989 https://doi.org/10.1016/j.waojou.2021.100610 DOI: https://doi.org/10.1016/j.waojou.2021.100610
Metz M, Vadasz Z, Kocatürk E, Giménez-Arnau AM. Omalizumab updosing in chronic spontaneous urticaria: an overview of real-world evidence. Clin Rev Allergy Immunol. 2020;59(1):38-45. https://pubmed.ncbi.nlm.nih.gov/32418171 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351799 https://doi.org/10.1007/s12016-020-08794-6 DOI: https://doi.org/10.1007/s12016-020-08794-6
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Maria Francesca Emily Z. Geraldez, MD , Shirley Kwong-Buizon, MD, FPPS, FPSAAI
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
